Overture Life Raises $15M in Series B Funding
- Overture Life, a Madrid, Spain-based IVF process automation startup, raised $15M in Series B funding
- The round, which brought total fundraising to $37M, was led by Octopus Ventures, with participation from GV, as well as existing investors
- The company intends to use the funds to increase its operations in Europe and the US and begin commercialization of its first products
- verture Life is developing medical devices and novel embryo testing methodologies that will automate all stages of the IVF process, lowering costs
- The devices are being developed in its facilities located in Madrid and Barcelona
- Overture currently employs 60 multidisciplinary specialists across the fields of software, microfluidics, robotics, embryology, and reproductive medicine
